Viatris (VTRS) Gross Margin (2020 - 2026)
Viatris' (VTRS) quarterly Gross Margin came in at 32.97% in Q1 2026, down 271.0% year-on-year from 19.28% in Q1 2025, and up 7.43% quarter-over-quarter from 30.69% in Q4 2025.
Viatris (VTRS) Gross Margin (2020 - 2026) Analysis & Trends
Viatris' Gross Margin history runs 7 years deep, the most recent figure standing at 32.97% for Q1 2026.
- On a quarterly basis, Gross Margin fell 271.0% year-over-year to 32.97% in Q1 2026; TTM through Mar 2026 was 34.36%, a 264.0% decrease from a year earlier, with the FY2025 full-year figure at 35.06%, down 321.0% from the prior year.
- Gross Margin improved to 32.97% in Q1 2026 per VTRS's latest filing, from 30.69% in the prior quarter.
- Across five years, Gross Margin topped out at 42.99% in Q3 2023 and bottomed at 30.69% in Q4 2025.
- The 5-year median for Gross Margin is 38.9% (2024), against an average of 38.42%.
- Across the five-year window, Gross Margin surged 1677 bps in 2022 and tumbled 713 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 32.57% in 2022, then gained by 29 bps to 42.03% in 2023, then fell by 17 bps to 34.9% in 2024, then fell by 12 bps to 30.69% in 2025, then climbed by 7 bps to 32.97% in 2026.
- Per Business Quant, the three latest VTRS Gross Margin figures stand at 32.97% (Q1 2026), 30.69% (Q4 2025), and 36.48% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 55.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.97% |
| Dec 31, 2025 | 30.69% |
| Sep 30, 2025 | 36.48% |
| Jun 30, 2025 | 37.35% |
| Mar 31, 2025 | 35.68% |
| Dec 31, 2024 | 34.90% |
| Sep 30, 2024 | 38.90% |
| Jun 30, 2024 | 38.18% |
| Mar 31, 2024 | 41.05% |
| Dec 31, 2023 | 42.03% |
| Sep 30, 2023 | 42.99% |
| Jun 30, 2023 | 41.05% |
| Mar 31, 2023 | 41.36% |
| Dec 31, 2022 | 32.57% |
| Sep 30, 2022 | 42.99% |
| Jun 30, 2022 | 41.49% |
| Mar 31, 2022 | 42.39% |
| Dec 31, 2021 | 35.11% |
| Sep 30, 2021 | 34.82% |
| Jun 30, 2021 | 29.11% |